Martin V. Hamann

Hamburg, HH, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapy.

Development of a recombinant adeno-associated virus vector for human T lymphocyte- and natural killer cell-targeted gene therapy.

Journal: bioRxiv : the preprint server for biology

Published: May 13, 2026

Defective proviruses cause T cell reprogramming through promoter exaptation in HIV-1 infection.

Defective proviruses cause T cell reprogramming through promoter exaptation in HIV-1 infection.

Journal: bioRxiv : the preprint server for biology

Published: October 03, 2025

Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes.

Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes.

Expression of LTR and LINE1 transposable elements defines atypical teratoid/rhabdoid tumor subtypes.

Journal: Acta neuropathologica communications

Published: May 11, 2025

Confounding factors in profiling of locus-specific human endogenous retrovirus (HERV) transcript signatures in primary T cells using multi-study-derived datasets.

Confounding factors in profiling of locus-specific human endogenous retrovirus (HERV) transcript signatures in primary T cells using multi-study-derived datasets.

Journal: BMC medical genomics

Published: January 17, 2023

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.

Improved targeting of human CD4+ T cells by nanobody-modified AAV2 gene therapy vectors.

Journal: PloS one

Published: July 29, 2021

Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene.

Transcriptional behavior of the HIV-1 promoter in context of the BACH2 prominent proviral integration gene.

Journal: Virus research

Published: November 26, 2020

TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.

TraFo-CRISPR: Enhanced Genome Engineering by Transient Foamy Virus Vector-Mediated Delivery of CRISPR/Cas9 Components.

Journal: Molecular therapy. Nucleic acids

Published: February 15, 2019

STK3 is a therapeutic target for a subset of acute myeloid leukemias.

STK3 is a therapeutic target for a subset of acute myeloid leukemias.

Journal: Oncotarget

Published: December 17, 2017

Correction: Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.

Correction: Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.

Journal: PLoS pathogens

Published: October 11, 2016

Foamy Virus Protein-Nucleic Acid Interactions during Particle Morphogenesis.

Foamy Virus Protein-Nucleic Acid Interactions during Particle Morphogenesis.

Journal: Viruses

Published: June 29, 2016

Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.

Interactions of Prototype Foamy Virus Capsids with Host Cell Polo-Like Kinases Are Important for Efficient Viral DNA Integration.

Journal: PLoS pathogens

Published: March 13, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026